Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial

Peer Review reports

Original Submission
22 Jul 2020	Submitted	Original manuscript
6 Jan 2021	Author responded	Author comments - Asieh Mansour
3 Dec 2020	Reviewed	Reviewer Report - Marius Baranauskas
11 Dec 2020	Reviewed	Reviewer Report - Dalia El Khoury
Resubmission - Version 2
6 Jan 2021	Submitted	Manuscript version 2
20 Feb 2021	Author responded	Author comments - Asieh Mansour
21 Jan 2021	Reviewed	Reviewer Report - Marius Baranauskas
11 Jan 2021	Reviewed	Reviewer Report - Dalia El Khoury
Resubmission - Version 3
20 Feb 2021	Submitted	Manuscript version 3
Publishing
3 Apr 2021	Editorially accepted
10 Apr 2021	Article published	10.1186/s12937-021-00694-5

Back to article page